Drug Shortage Report for TARO-MELPHALAN

Last updated on 2025-03-17 History
Report ID 248954
Drug Identification Number 02480026
Brand name TARO-MELPHALAN
Common or Proper name MELPHALAN
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) BUFFER SOLUTION MELPHALAN
Strength(s) 10ML 50MG
Dosage form(s) POWDER FOR SOLUTION KIT
Route of administration INTRAVENOUS INTRA-ARTERIAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10mL Vial
ATC code L01AA
ATC description ALKYLATINGAGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-10-31
Estimated end date 2025-03-07
Actual end date 2025-03-03
Shortage status Resolved
Updated date 2025-03-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-03-17 French Compare
v7 2025-03-17 English Compare
v6 2025-02-21 French Compare
v5 2025-02-21 English Compare
v4 2025-02-10 French Compare
v3 2025-02-10 English Compare
v2 2025-01-28 French Compare
v1 2025-01-28 English Compare

Showing 1 to 8 of 8